The oncogenic miR-429 promotes triple-negative breast cancer progression by degrading DLC1

Lines of evidence have demonstrated that the oncogenic miRNAs are pivotal to the progression of breast cancer. In this study, we investigated the biological traits of microRNA-429 (miR-429) in triple-negative breast cancer (TNBC) and the underlying molecular mechanism. We found that miR-429 was nota...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yao, Meng, Xue, Luo, Yuqing, Luo, Shuai, Li, Jin, Zeng, Jiafei, Huang, Xiang, Wang, Jinjing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564445/
https://www.ncbi.nlm.nih.gov/pubmed/37737712
http://dx.doi.org/10.18632/aging.205051
Descripción
Sumario:Lines of evidence have demonstrated that the oncogenic miRNAs are pivotal to the progression of breast cancer. In this study, we investigated the biological traits of microRNA-429 (miR-429) in triple-negative breast cancer (TNBC) and the underlying molecular mechanism. We found that miR-429 was notably overexpressed in TNBC, and promoted TNBC cell proliferation, migration, and invasion by degrading the tumor suppressor DLC1. In conclusion, our findings reveal the mechanism of tumorigenic miR-429 in TNBC, which paves the way for target therapies translation in clinical settings.

Ejemplares similares